Latest profit margin for Conformis: -72.73% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
Conformis (CFMS) currently reports a profit margin of -72.73% as of June 2023. That compares with -99.97% in the prior-year period — up 27.3% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore Conformis's profit margin history and peer comparisons.
Conformis's profit margin increased from -99.97% to -72.73% — a 27.3% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Conformis's profit margin of -72.73% is lower than the Healthcare sector average of 14.41%. That is roughly 604.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Conformis's current -72.73% should be judged against Healthcare norms (sector average: 14.41%) and against CFMS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -72.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for Conformis, and consider following CFMS for alerts when major investors trade the stock.